NCT06293053 - A Study to Investigate the Pharmacokinetics and Safety of Dupilumab in Participants ≥6 Months to <18 Years of Age With Prurigo Nodularis | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 15, 2024

Primary Completion Date

October 28, 2027

Study Completion Date

November 3, 2027

Conditions

Prurigo Nodularis

Interventions

DRUG

Dupilumab

"Pharmaceutical form: Injection solution~Route of administration: Subcutaneous"

Trial Locations (14)

33012

RECRUITING

Direct Helpers Research Center- Site Number : 8400015, Hialeah

33071

RECRUITING

Life Clinical Trials - Coral Springs- Site Number : 8400018, Coral Springs

33146

RECRUITING

Pediatric Center of Excellence (PCE) - Miami Pediatric Endocrinology, LLC- Site Number : 8400005, Coral Gables

33558

RECRUITING

Suncoast Skin Solutions- Site Number : 8400008, Lutz

33606

RECRUITING

USF Health - Dermatology and Cutaneous Surgery - Davis Blvd Location (Pediatric Dermatology)- Site Number : 8400003, Tampa

55123

RECRUITING

Tareen Dermatology- Site Number : 8400022, Eagan

58103

RECRUITING

Axis Clinicals- Site Number : 8400013, Fargo

64506

RECRUITING

MediSearch Clinical Trials (Dermatology)- Site Number : 8400004, Saint Joseph

74136

RECRUITING

Vital Prospects Clinical Research Institute, P.C.- Site Number : 8400002, Tulsa

77090

RECRUITING

1960 Family Practice- Site Number : 8400009, Houston

78218

RECRUITING

Texas Dermatology and Laser Specialists- Site Number : 8400020, San Antonio

78411

RECRUITING

Driscoll Children's Hospital- Site Number : 8400017, Corpus Christi

78723

RECRUITING

Dell Children's Medical Center- Site Number : 8400007, Austin

92688

RECRUITING

Mission Dermatology Center- Site Number : 8400011, Rancho Santa Margarita